Dr. Napper's research is looking to develop new treatments for hard to treat types of acute lymphocyctic leukemia (ALL), specifically MLL rearranged leukemia. This type of the disease is very aggressive, common in infants and can often lead to a grim prognosis for these young children as current therapies are often unsuccessful.With the research funding from ALSF, Dr. Napper and his team have developed a screening tool that allows them to quickly test several hundred thousand compounds (compounds that can lead to new therapies) until they find one with promise.
Watch the video below to hear from Dr. Napper and learn more about his encouraging research project restoring hope in kids and families afflicted by ALL. Forward this to a friend! Spread the word about why supporting childhood cancer research is vital to saving children's lives.